Literature DB >> 17440439

Androgen receptor CAG repeat length contraction in diseased and non-diseased prostatic tissues.

K Sircar1, B Gottlieb, C Alvarado, A Aprikian, L K Beitel, M Alam-Fahmy, L Begin, M Trifiro.   

Abstract

To investigate contraction of CAG repeats within the androgen receptor gene (AR) as shorter CAG repeats have been implicated as a possible risk factor in prostate cancer (PCa). AR CAG repeat lengths were analyzed in DNA from microdissected diseased prostates, leukocytes from matched peripheral blood, and control non-diseased prostates. Consistently, all prostatic tissues, whether from benign or cancerous areas of diseased prostates, or from control prostates, showed multiple AR CAG repeat contractions. Germline DNA from blood leukocytes had single CAG repeat lengths in the normal range. AR CAG repeat length contraction may be involved in prostate carcinogenesis and may precede the pathological process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17440439     DOI: 10.1038/sj.pcan.4500967

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  5 in total

Review 1.  Selection and mutation in the "new" genetics: an emerging hypothesis.

Authors:  Bruce Gottlieb; Lenore K Beitel; Carlos Alvarado; Mark A Trifiro
Journal:  Hum Genet       Date:  2010-01-23       Impact factor: 4.132

Review 2.  The complexity of prostate cancer: genomic alterations and heterogeneity.

Authors:  Lara K Boyd; Xueying Mao; Yong-Jie Lu
Journal:  Nat Rev Urol       Date:  2012-11       Impact factor: 14.432

3.  Germline Mutations and Polymorphisms of Androgen Receptor in Prostate Cancer Patients: Frequency and Results of in Silico Analysis

Authors:  Yunia Sribudiani; Deineke W Marwan; Aulanni’am Aulanni’am; Muhammad A Widodo; Basuki B Purnomo; Ramdan Panigoro; Ahmad B Utomo
Journal:  Asian Pac J Cancer Prev       Date:  2018-08-24

4.  Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer.

Authors:  Chia-Cheng Yu; Shu-Pin Huang; Yung-Chin Lee; Chao-Yuan Huang; Chia-Chu Liu; Tzyh-Chyuan Hour; Chun-Nung Huang; Bang-Jau You; Ta-Yuan Chang; Chun-Hsiung Huang; Bo-Ying Bao
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

Review 5.  Diverse roles of androgen receptor (AR) domains in AR-mediated signaling.

Authors:  Frank Claessens; Sarah Denayer; Nora Van Tilborgh; Stefanie Kerkhofs; Christine Helsen; Annemie Haelens
Journal:  Nucl Recept Signal       Date:  2008-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.